TITLE

The treatment of ocular tuberculosis: a survey of published literature

AUTHOR(S)
Mehta, Salil
PUB. DATE
December 2006
SOURCE
Indian Journal of Ophthalmology;Dec2006, Vol. 54 Issue 4, p278
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
With an expanding awareness of ocular tuberculosis, ophthalmologists are increasingly required to participate in the care of these patients. We conducted a survey of published ophthalmic literature to identify whether the regimens of antitubercular medications prescribed conform to current guidelines. A Medline search for publications (1995-2005) was done and the data were systematically analyzed with respect to demographic features, clinical findings and the antitubercular therapy prescribed. Of the 34 papers (82 patients) available, 33 papers described the prescribed antitubercular therapy. Eighteen papers (54.5%, 46 patients) conformed to guidelines versus 15 papers (45.4%, 32 patients) did not, suggesting that a large proportion of papers do not conform to current guidelines. Wider dissemination of therapeutic guidelines is necessary to encourage rational therapy and minimize therapeutic failures, drug resistance or relapse.
ACCESSION #
23130812

 

Related Articles

  • Totally drug-resistant tuberculosis (TDR-TB) in India: every dark cloud has a silver lining. Udwadia, Zarir; Vendoti, Deepesh // Journal of Epidemiology & Community Health;Jun2013, Vol. 67 Issue 6, p471 

    The authors discuss totally drug-resistant tuberculosis (TDR-TB) which is a generic term for tuberculosis strains are resistant to drugs than strains classified as extensively drug-resistant tuberculosis. They mention that TDR-TB in India has resulted from further mutations within the bacterial...

  • Challenges in tuberculosis drug research and development. Ginsberg, Ann M.; Spigelman, Melvin // Nature Medicine;Mar2007, Vol. 13 Issue 3, p290 

    The article discusses the challenges faced by researchers in tuberculosis (TB) drug research and development. The early part of the twenty-first century has seen a reawakening of drug research and development for TB, spurred on by an urgent need to stem the tide of the disease globally and...

  • Defining the 'survivasome' of Mycobacterium tuberculosis. Lamichhane, Gyanu; Bishai, William // Nature Medicine;Mar2007, Vol. 13 Issue 3, p280 

    The article investigates Mycobacterium tuberculosis persistence despite the availability of drugs that than can stably cure it by researchers from Baltimore, Maryland. Identification of drug targets in M. tuberculosis has been a challenge for researchers. However, high-throughput mutagenesis...

  • Good policies help improve labeling.  // Healthcare Risk Management;Sep2008, Vol. 30 Issue 9, p105 

    The article discusses the policies and procedures which help reduce the risks in using unlabeled syringes.

  • A Retrospective Analysis of Isoniazid-Monoresistant Tuberculosis: Among Iranian Pulmonary Tuberculosis Patients. Varahram, Mohammad; Javad Nasiri, Mohammad; Farnia, Parissa; Mozafari, Mohadese; Akbar Velayati, Ali // Open Microbiology Journal;2014, Vol. 8, p1 

    Background and objectives: Isoniazid (INH) is one of the most potent anti-tuberculosis (TB) drugs. The spread and transmission of INH-resistant bacilli are likely to pose a significant problem for National TB control Program (NTP). In this study, we aimed to determine the trend of...

  • DR-TB drugs under the microscope. Ravi Shankar, P. // Australasian Medical Journal;2013, Vol. 6 Issue 1, p65 

    The article reviews the book "DR-TB Drugs Under the Microscope: Sources and Prices for Drug-Resistant Tuberculosis Medicines," 2nd edition, by the Medicins sans Frontieres (MSF) Access Campaign and the International Union Against Tuberculosis and Lung Disease.

  • Leber's hereditary optic neuropathy masquerading as ethambutol-induced optic neuropathy in a young male. Chowdhury, Bithi; Nagpaul, A. K.; Chowdhury, Debashish // Indian Journal of Ophthalmology;Sep2006, Vol. 54 Issue 3, p218 

    A letter to the editor is presented is response to an article regarding molecular characterization in two Indian families with Lebre's hereditary optic neuropathy.

  • Part IV: Clinical Case Studies in Combination Glaucoma Drugs.  // Review of Ophthalmology;Feb2007 Part 1 of 2, Vol. 14 Issue 2, p73 

    The article presents clinical case studies of patients with eye disease and treated with a combination of glaucoma drugs. One of the case involves a 75-year old Caucasian female with psudoexofoliative glaucoma in the right eye. The patient was treated with a combination agent of Xalacom to...

  • Delamanid for multidrug-resistant pulmonary tuberculosis.  // African Journal of Respiratory Medicine;Sep2012, Vol. 8 Issue 1, p2 

    The article reports on the multicentre trial reported in the "New England Journal of Medicine" which shows the effectiveness of the antituberculous drug delamanid for treatment of multidrug-resistant pulmonary tuberculosis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics